Diffuse Midline Glioma
Therapeutic response
Precision oncology relationships for therapeutic response involving this cancer type.
| Organization(s) | Biomarker(s) | Cancer type | Therapy(ies) | |
|---|---|---|---|---|
| FDA (1) | H3-3A p.K27M | Diffuse Midline Glioma | Dordaviprone |
Precision oncology relationships for therapeutic response involving this cancer type.
| Organization(s) | Biomarker(s) | Cancer type | Therapy(ies) | |
|---|---|---|---|---|
| FDA (1) | H3-3A p.K27M | Diffuse Midline Glioma | Dordaviprone |